Okyanos Heart Institute’s blog provides a place where heart disease patients, their caregivers and physicians can keep up with the latest information on advancements in cell therapy treatment from around the globe.
On March 23, 2011 my heart stopped beating. Technically I died, and it was the single most valuable experience I have ever had. My story is your story. Eventually we all reach that moment in life when have to face our fears. Did you know a moose will hide behind a tree when it senses …
view »Hear from Okyanos Heart Institute’s Chief Medical Officer in this video describing why cardiac stem cell therapy is the future of medicine for chronic coronary artery disease.
view »In 2001, Doctors Emerson Perin and James Willerson were the principle investigators on the first stem cell therapy trial for chronic coronary artery disease. Since that trial, they have discovered the advantages of using adipose tissue as a source of stem cells.
view »Findings from the recent randomized POSEIDON clinical trial showed significant reduction in previous heart attack scar damage and promising improvements in heart function.
view »Learn what patients can expect during a stay at Okyanos in this interview with Gretchen Dezelick, Director of Nursing at Okyanos Heart Institute.
view »In this interview, Matt reveals how the vision of Okyanos has become a new option available today for chronic coronary artery disease cardiac patients who received maximal conventional treatments. As you’ll soon learn, it’s a personal journey.
view »In this blog post, Dr. Howard Walpole, MD, Chief Medical Officer, answers frequently asked questions about the Okyanos patient registry, which is a database of information organized by certain criteria for a given disease state.
view »As an interventional cardiologist, I am excited to see a meta-analysis of trials using adult bone marrow stem cells (BMCs) for the treatment of coronary artery disease for both post-heart attack and patients with chronic CAD. This post reviews promising cardiac studies with bone marrow highlighting the significant potential of this relatively new approach, namely using cells, to treat ischemic disease.
view »Obesity has received much public attention over the last few years as a worsening epidemic and a risk factor for a number of diseases. A recent study published in the Journal of Clinical Endocrinology & Metabolism suggested that obese people are not inevitably at increased risk of cardiovascular disease and death.
view »At the American College of Cardiology’s 61st annual convention, the spotlight on stem cell therapy for heart disease has never been brighter. Several sessions presented the latest developments in this fast-growing field.
view »